The practical drivers we see most often are simpler than brain chemistry: rapid change, lower energy, under-eating, nausea, and shifting body image
This article explains why peptide medicines like retatrutide are challenging to deliver orally, where retatrutide currently sits in its clinical development programme, and which licensed weight management medicines are available in the UK today
But some previous clinical trials found that people lost up to 20% of their body weight while on these GLP-1 drugs
Going back to work Talk with your healthcare provider about your job
extensive post-market safety data Advantage : Tirzepatide Liver Fat Reduction# Retatrutide : Significant hepatic fat reduction via glucagon receptor activation (up to 82% reduction) Tirzepatide : Moderate hepatic fat reduction observed in trials Advantage : Retatrutide Dosing Convenience# Retatrutide : Once-weekly subcutaneous injection Tirzepatide : Once-weekly subcutaneous injection with established titration schedule Advantage : Neither (tie) Summary and Verdict# Tirzepatide is the proven choice with FDA approval and extensive clinical data
Thats not what microdosing is for
